VC fund, DCVC Bio, invests in early-stage computational biology startups transforming life sciences.
Location
Palo Alto, CA, US
Founded
2018
DCVC Bio is a venture capital fund specializing in early-stage computational biology startups. The firm focuses on companies leveraging advances in genetic sequencing, artificial intelligence, and automation to transform life sciences technologies. Their investment interests span synthetic biology, medicine, and agriculture, with a particular emphasis on startups shaping the biochemical building blocks of the life sciences industry.
The fund's portfolio includes notable companies such as AbCellera Biologics, Chroma Medicine, and Pivot Bio. DCVC Bio has participated in numerous Series A rounds, as well as seed and Series B investments. The firm's approach combines deep technological expertise with a focus on startups poised to make significant impacts in their respective fields, supporting innovations that address critical challenges in healthcare, sustainability, and biotechnology.
Dcvc Bio - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
